562 related articles for article (PubMed ID: 23289539)
1. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
[TBL] [Abstract][Full Text] [Related]
2. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
3. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
4. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
[TBL] [Abstract][Full Text] [Related]
5. Letter: serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease.
Rodríguez-Martín L; Vaquero L; Vivas S
Aliment Pharmacol Ther; 2015 Jul; 42(1):121-2. PubMed ID: 26040522
[No Abstract] [Full Text] [Related]
6. Letter: serum I-FABP as marker for enterocyte damage in first-degree relatives of patients with coeliac disease - authors' reply.
Adriaanse MP; Buurman WA; Vreugdenhil AC
Aliment Pharmacol Ther; 2015 Jul; 42(1):122. PubMed ID: 26040523
[No Abstract] [Full Text] [Related]
7. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
Adriaanse MP; Leffler DA; Kelly CP; Schuppan D; Najarian RM; Goldsmith JD; Buurman WA; Vreugdenhil AC
Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
[TBL] [Abstract][Full Text] [Related]
8. Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease.
Oldenburger IB; Wolters VM; Kardol-Hoefnagel T; Houwen RHJ; Otten HG
APMIS; 2018 Mar; 126(3):186-190. PubMed ID: 29383769
[TBL] [Abstract][Full Text] [Related]
9. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
10. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease.
Alessio MG; Tonutti E; Brusca I; Radice A; Licini L; Sonzogni A; Florena A; Schiaffino E; Marus W; Sulfaro S; Villalta D;
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):44-9. PubMed ID: 22197946
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP.
Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA
J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998
[TBL] [Abstract][Full Text] [Related]
12. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study.
Carroccio A; Brusca I; Iacono G; Alessio MG; Sonzogni A; Di Prima L; Barrale M; Ottomano C; Ambrosiano G; Teresi S; D'Angelo A; Pirrone G; Cefalù B; Scalici C; La Chiusa SM
Dig Liver Dis; 2007 Sep; 39(9):818-23. PubMed ID: 17652043
[TBL] [Abstract][Full Text] [Related]
13. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
[TBL] [Abstract][Full Text] [Related]
14. Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP.
Adriaanse MPM; Mubarak A; Riedl RG; Ten Kate FJW; Damoiseaux JGMC; Buurman WA; Houwen RHJ; Vreugdenhil ACE;
Sci Rep; 2017 Aug; 7(1):8671. PubMed ID: 28819290
[TBL] [Abstract][Full Text] [Related]
15. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
[TBL] [Abstract][Full Text] [Related]
16. Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
Laass MW; Röber N; Range U; Noß L; Roggenbuck D; Conrad K
PLoS One; 2015; 10(6):e0128104. PubMed ID: 26047356
[TBL] [Abstract][Full Text] [Related]
17. [Zonulin and I-FABP are markers of enterocyte damage in celiac disease].
Bykova SV; Sabelnikova EA; Novikov AA; Baulo EV; Khomeriki SG; Parfenov AI
Ter Arkh; 2022 May; 94(4):511-516. PubMed ID: 36286801
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
[TBL] [Abstract][Full Text] [Related]
19. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
20. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
